Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kaprolac K301 for Seborrhoeic Eczema of the Scalp
NCT01137331Phase 3Completed
- Sponsor
- Moberg Pharma AB
- Start
- Feb 2008
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Kaprolac in seborrheic dermatitis (SD), sponsored by Moberg Pharma AB. Started Feb 2008; status: completed.
02
Drugs
Kaprolac
03
Conditions
seborrheic dermatitis (SD)
Beyond the preview
Go deeper on NCT01137331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01137331.